Quick answers
- What is Gimoti?
- Gimoti is a brand name of Metoclopramide, a prescription medicine. The FDA NDC Directory lists 1 Gimoti product in 1 strength and form.
- Who makes Gimoti?
- Qol Medcl holds the FDA application for Gimoti (NDA209388, approved June 19, 2020).
- Is there a generic or store brand of Gimoti?
- Other products of Metoclopramide are listed with the FDA, but none in exactly the same strength and form as a Gimoti product.
- Has Gimoti been recalled?
- No recall linked to Gimoti products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Gimoti is
Each Gimoti product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Metoclopramide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| metoclopramide hydrochloride 15 mg/0.07 mL spray (nasal) | Gimoti | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Metoclopramide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA209388 | Qol Medcl | June 19, 2020 | 1 |
Companies that list Gimoti
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Gimoti products.
- Evoke Pharma, Inc.1 product
Recalls
No recall linked to Gimoti products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.